Skip to content

Clinical trials

Expanded access Neuroblastoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuroblastoma Phase: Expanded access Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

No trials to chart.

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Available6
No longer available6
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
British Columbia Cancer Agency1
Children's Hospital Medical Center, Cincinnati1
GE Healthcare1
Giselle Sholler1
John Maris1
Jubilant DraxImage Inc.1
Kieuhoa Vo1
Memorial Sloan Kettering Cancer Center1
Northwell Health1
ProgenaBiome1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuroblastoma13
Pheochromocytoma5
Paraganglioma3
Recurrence3
Medulloblastoma2
Neuroectodermal Tumors, Primitive2
Carcinoid Tumor1
Carcinoma, Non-Small-Cell Lung1
Dysbiosis1
Gastrointestinal Neoplasms1

Trials

Showing 26 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.